These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28816009)
1. Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro. Song S; Ji Y; Zhang G; Zhang X; Li B; Li D; Jiang W Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):199-207. PubMed ID: 28816009 [TBL] [Abstract][Full Text] [Related]
2. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo. Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405 [TBL] [Abstract][Full Text] [Related]
3. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo. Zhang L; Ji YX; Jiang WL; Lv CJ Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646 [TBL] [Abstract][Full Text] [Related]
13. Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition. Cui W; Li L; Li D; Mo X; Zhou W; Zhang Z; Xu L; Zhao P; Qi L; Li P; Gao J Inflamm Res; 2015 Dec; 64(12):953-61. PubMed ID: 26411348 [TBL] [Abstract][Full Text] [Related]
14. Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21. Zhou X; Li YJ; Gao SY; Wang XZ; Wang PY; Yan YF; Xie SY; Lv CJ J Cell Mol Med; 2015 May; 19(5):1103-13. PubMed ID: 25704671 [TBL] [Abstract][Full Text] [Related]
15. HIP/PAP protects against bleomycin-induced lung injury and inflammation and subsequent fibrosis in mice. Zheng X; Li Q; Tian H; Li H; Lv Y; Wang Y; He L; Huo Y; Hao Z J Cell Mol Med; 2020 Jun; 24(12):6804-6821. PubMed ID: 32352211 [TBL] [Abstract][Full Text] [Related]
16. Mushroom Inonotus sanghuang alleviates experimental pulmonary fibrosis: Implications for therapy of pulmonary fibrosis. Su X; Liu K; Xie Y; Zhang M; Wu X; Zhang Y; Wang J Biomed Pharmacother; 2021 Jan; 133():110919. PubMed ID: 33202282 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways. Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714 [TBL] [Abstract][Full Text] [Related]
18. Forsythoside A regulates pulmonary fibrosis by inhibiting endothelial-to-mesenchymal transition and lung fibroblast proliferation via the PTPRB signaling. Zhang Q; Zhang B; Yang F; Hu Y; Fan R; Wang M; Chen S Phytomedicine; 2024 Jul; 130():155715. PubMed ID: 38788399 [TBL] [Abstract][Full Text] [Related]
19. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis. Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178 [TBL] [Abstract][Full Text] [Related]
20. The role of high mobility group box1 in pulmonary fibrosis. Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]